Jun Yeon Lee

Title: Innovations of Jun Yeon Lee in Pain Management

Introduction

Jun Yeon Lee is an accomplished inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pain management through his innovative research and development. His work focuses on creating effective solutions for conditions involving Na1.7 activity.

Latest Patents

Jun Yeon Lee holds a patent for a groundbreaking invention titled "SCN9A antisense pain killer." This invention provides peptide nucleic acid derivatives that target the 3' splice site of exon 4 in the human SCN9A pre-mRNA. The peptide nucleic acid derivatives potently induce SCN9A mRNA splice variant(s) that lack the SCN9A exon 4 in cells. This innovation is particularly useful for safely treating pains or conditions associated with Na1.7 activity.

Career Highlights

Jun Yeon Lee is currently employed at Olipass Corporation, where he continues to advance his research in the field of pain management. His dedication to innovation has positioned him as a key figure in the development of new therapeutic approaches.

Collaborations

Some of his notable coworkers include Shin Chung and Daram Jung, who contribute to the collaborative efforts at Olipass Corporation. Their combined expertise enhances the potential for groundbreaking discoveries in pain management.

Conclusion

Jun Yeon Lee's innovative work in developing the SCN9A antisense pain killer exemplifies his commitment to improving pain management solutions. His contributions are paving the way for safer and more effective treatments for individuals suffering from pain-related conditions.